Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

BBOTBBOT
2 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

Ensign Peak Advisors, Inc holds 273,530 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $2.1M as of 2026-Q2. The position was decreased (-14.8% shares). BBOT represents 0.0% of Ensign Peak Advisors, Inc's portfolio.

Current Value

$2.1M

Current Shares

273,530

Total Value Change

-$787,523

Total Shares Change

-47,344

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
273,530
-14.8%
$2.1M0.0%$7.62
0
2026-Q1
New
320,874
-
$2.9M0.0%$9.74
36

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used